Updates in diagnosis and treatment of acromegaly

Research output: Contribution to journalReview articlepeer-review

45 Scopus citations


Acromegaly is a rare disease, caused largely by a growth hormone (GH) pituitary adenoma. Incidence is higher than previously thought. Due to increased morbidity and mortality, if not appropriately treated, early diagnosis efforts are essential. Screening is recommended for all patients with clinical features of GH excess. There is increased knowledge that classical diagnostic criteria no longer apply to all, and some patients can have GH excess with normal GH response to glucose. Treatment is multifactorial and personalised therapy is advised.

Original languageEnglish (US)
Pages (from-to)57-61
Number of pages5
JournalEuropean Endocrinology
Issue number2
StatePublished - Sep 1 2018


  • Acromegaly
  • Growth hormone
  • Pituitary adenoma
  • Somatostatin receptor ligand

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Endocrine and Autonomic Systems


Dive into the research topics of 'Updates in diagnosis and treatment of acromegaly'. Together they form a unique fingerprint.

Cite this